Anti-human FLT1 monoclonal antibody, icrucumab biosimilar, Biotinylated

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1420-100ug

  • Size

    100ug

  • Price

    $450

1
This antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
note Other commonly used names in publications refering to this antibody: 18F1, IMC-18F1, LY3012212
target FLT1
alias FLT, FLT-1, VEGFR-1, VEGFR1
gene id Uniprot ID: P17948
host species Human
reactivity Human
iso type IgG1
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml
applications ELISA
dilution ELISA 1:5000-10000
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.

Images

Elisa plates were pre-coated with Human FLT1 Protein with hFc Tag (0.2ug/per well). Serial diluted Biotinylated Anti-FLT1 (icrucumab biosimilar) mAb solutions were added, washed, and incubated with SA-HRP before Elisa reading. From above data, the EC50 for Biotinylated Anti-FLT1 (icrucumab biosimilar)monoclonal antibody binding with FLT1 Protein ,hFc Tag is 15.9 ng/ml.


PRODUCT

  • SKU

    DMS1420-100ug

  • Size

    100ug

  • Price

    $450

1